Abstract:

In the clinical management of newly diagnosed patients with human immunodeflciency virus (HIV) infection, issues such as delayed initiation of antiretroviral therapy (ART), non-standardized pre-treatment clinical evaluations, and untimely therapeutic efficacy monitoring persist, all of which adversely affect disease control and prognosis.In order to enhance the quality of diagnosis and treatment for HIV-infected patients, the expert panel from the National Medical Quality Control Center for Infectious Diseases has formulated a set of quality control indicators based on global research advancements and China’s clinical experience on HIV management.These indicators include: pretreatment assessment rate for newly diagnosed patients, proportion of ART initiation within 7 days after HIV infection diagnosis,therapeutic efficacy evaluation rate and success rate at 6 months post-ART initiation, and mortality rate among hospitalized acquired immunodeficiency syndrome (AIDS) patients.To guide healthcare institutions at all levels in implementing these quality metrics, the National Medical Quality Control Center for Infectious Diseases has organized experts to develop this consensus document, which provides recommendations regarding the clinical signiflcance of HIV quality control indicators, standardized data collection through information systems, and continuous quality improvement strategies for hospital-based HIV care services.

Key words: Human immunodeficiency virus infection, Anti-retroviral therapy, Acquired immunodeflciency syndrome, CD4⁺ T leukomonocyte